U.S. Markets open in 52 mins
  • S&P Futures

    4,119.50
    -7.00 (-0.17%)
     
  • Dow Futures

    33,670.00
    -33.00 (-0.10%)
     
  • Nasdaq Futures

    13,743.00
    -51.25 (-0.37%)
     
  • Russell 2000 Futures

    2,185.80
    +1.80 (+0.08%)
     
  • Crude Oil

    61.31
    -1.36 (-2.17%)
     
  • Gold

    1,785.40
    +7.00 (+0.39%)
     
  • Silver

    26.17
    +0.33 (+1.26%)
     
  • EUR/USD

    1.2012
    -0.0029 (-0.2402%)
     
  • 10-Yr Bond

    1.5700
    +0.0080 (+0.51%)
     
  • Vix

    18.64
    +1.35 (+7.81%)
     
  • GBP/USD

    1.3921
    -0.0016 (-0.1155%)
     
  • USD/JPY

    107.9990
    -0.0710 (-0.0657%)
     
  • BTC-USD

    55,206.68
    -693.91 (-1.24%)
     
  • CMC Crypto 200

    1,266.15
    +31.73 (+2.57%)
     
  • FTSE 100

    6,875.24
    +15.37 (+0.22%)
     
  • Nikkei 225

    28,508.55
    -591.83 (-2.03%)
     

IHS Markit (INFO) to Post Q1 Earnings: What's in Store?

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
Zacks Equity Research
·3 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

IHS Markit Ltd. INFO is scheduled to release first-quarter fiscal 2020 results on Mar 24, before the bell.

Shares of the company have inched up 1.3% in the past year against the industry’s decline of 8.3%.

Q4 Highlights

In fourth-quarter fiscal 2019, IHS Markit’s total revenues of $1.12 billion increased 5% on a year-over-year basis.

In fiscal fourth quarter, the company delivered adjusted EPS of 65 cents, up 14% year over year.

Q1 Expectations

The Zacks Consensus Estimate for revenues in the to-be-reported quarter is pegged at $1.08 billion, which indicates year-over-year growth of 3.4%. The top line is likely to have gained fromthe Transportation and Financial Services segments.

The consensus estimate for revenues in the Transportation segment isat $299 million, which indicates year-over-year increase of 3.8%. Strong performance across CARFAX’s used car listing and vehicle history report product offerings, compliance product offerings and increase in automotiveMastermind revenues are expected to have boosted the segment’s performance in the quarter to be reported.

The consensus mark for revenues in the Financial Services segment is pegged at $434 million, which indicates year-over-year growth of 6.1%.Strength in information and solutions product offerings as well as strong performance of Ipreo might have had a positive impact on the segment’s performance in the to-be-reported quarter.

The consensus mark for earnings per share (EPS) in the to-be-reported quarter is pegged at 63 cents, which indicates year-over-year growth of 5%. Margin expansion from revenue growth is expected to have boosted the company’s fiscal first-quarter bottom line.

Zacks Rank and Stocks to Consider

Currently, IHS Markit carries a Zacks Rank #3 (Hold).

Few better-ranked stocks in the broader Zacks Business Services sector are Sykes Enterprises SYKE, Omnicom OMC and Genpact G, each carrying a Zacks Rank #2 (Buy).You can see  the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Long-term expected EPS (three to five years) growth rate for Sykes, Omnicom and Genpact is pegged at 10%, 5.6% and 14%, respectively.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Omnicom Group Inc. (OMC) : Free Stock Analysis Report
 
Sykes Enterprises, Incorporated (SYKE) : Free Stock Analysis Report
 
Genpact Limited (G) : Free Stock Analysis Report
 
IHS Markit Ltd. (INFO) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research